Background: Beta cells are central in the pathophysiology of diabetes, since their functional adaptation maintains euglycemia in insulin-resistant individuals and beta cell dysfunction is required for the clinical picture of frank diabetes. The pathophysiological mechanisms driving compensation and decompensation are incompletely understood and little is known about the influence of chronic kidney disease (CKD) on beta cell function. Summary: In compensated insulin resistance, beta cells enhance their function at all stages in the stimulus-secretion coupling cascade, from the most proximal membrane depolarization to the intermediate increase in intracellular calcium concentration and the most distal granule fusion. Intercellular coupling is not disrupted at this early stage during disease progression. Later during progression, when hyperglycemia becomes more apparent owing to insufficient beta cell compensation, intracellular stimulus-secretion coupling becomes enhanced to an even larger degree, but intercellular coupling becomes disrupted, indicating that ineffective cell-to-cell signal transmission may be the earliest event in progression to frank diabetes. CKD can negatively affect beta cell function through increased levels of urea that reduce beta cell glucose utilization and impair insulin secretion, and possibly also through factors other than urea. It remains to be investigated whether urea and other factors of CKD can also affect intercellular coupling. Key messages: Beta cells enhance intracellular stimulus-secretion coupling in early insulin resistance. With worsening insulin resistance, intracellular coupling enhances even more, but intercellular coupling becomes disrupted. CKD negatively impacts beta cell function, but its influence on intercellular coupling awaits further studies.

Keywords:
Beta cell, Adaptation, Dysfunction, Urea
1.
Skelin Klemen M, Dolenšek J, Slak Rupnik M, Stožer A: The triggering pathway to insulin secretion: functional similarities and differences between the human and the mouse β cells and their translational relevance. Islets 2017; 9: 109–139.
2.
Gonzalez A, Merino B, Marroquí L, Ñeco P, Alonso-Magdalena P, Caballero-Garrido E, Vieira E, Soriano S, Gomis R, Nadal A, Quesada I: Insulin hypersecretion in islets from diet-induced hyperinsulinemic obese female mice is associated with several functional adaptations in individual β-cells. Endocrinology 2013; 154: 3515–3524.
3.
White MG, Shaw JA, Taylor R: Type 2 diabetes: the pathologic basis of reversible β-Cell Dysfunction. Diabetes Care 2016; 39: 2080–2088.
4.
Irles E, Ñeco P, Lluesma M, Villar-Pazos S, Santos-Silva JC, Vettorazzi JF, Alonso-Magdalena P, Carneiro EM, Boschero AC, Nadal Á, Quesada I: Enhanced glucose-induced intracellular signaling promotes insulin hypersecretion: pancreatic beta-cell functional adaptations in a model of genetic obesity and prediabetes. Mol Cell Endocrinol 2015; 404: 46–55.
5.
Corkey BE: Banting Lecture 2011: Hyperinsulinemia: Cause or Consequence? Diabetes 2012; 61: 4–13.
6.
Templeman NM, Flibotte S, Chik JHL, Sinha S, Lim GE, Foster LJ, Nislow C, Johnson JD: Reduced Circulating Insulin Enhances Insulin Sensitivity in Old Mice and Extends Lifespan. Cell Rep 2017; 20: 451–463.
7.
Dolenšek J, Rupnik MS, Stožer A: Structural similarities and differences between the human and the mouse pancreas. Islets 2015; 7:e1024405.
8.
Ravier MA, Sehlin J, Henquin JC: Disorganization of cytoplasmic Ca(2+) oscillations and pulsatile insulin secretion in islets from ob/ob mice. Diabetologia 2002; 45: 1154–1163.
9.
Colsoul B, Jacobs G, Philippaert K, Owsianik G, Segal A, Nilius B, Voets T, Schuit F, Vennekens R: Insulin downregulates the expression of the Ca2+-activated nonselective cation channel TRPM5 in pancreatic islets from leptin-deficient mouse models. Pflugers Arch 2014; 466: 611–621.
10.
Park SH, Ryu SY, Yu WJ, Han YE, Ji YS, Oh K, Sohn JW, Lim A, Jeon JP, Lee H, Lee KH, Lee SH, Berggren PO, Jeon JH, Ho WK: Leptin promotes K(ATP) channel trafficking by AMPK signaling in pancreatic β-cells. Proc Natl Acad Sci U S A. 2013; 110: 12673–12678.
11.
Gosak M, Markovič R, Dolenšek J, Slak Rupnik M, Marhl M, Stožer A, Perc M: Network science of biological systems at different scales: a review. Phys Life Rev 2018; 118–135.
12.
Daraio T, Bombek LK, Gosak M, Valladolid-Acebes I, Klemen MS, Refai E, Berggren PO, Brismar K, Rupnik MS, Bark C: SNAP-25b-deficiency increases insulin secretion and changes spatiotemporal profile of Ca2+ oscillations in β cell networks. Sci Rep 2017; 7: 7744.
13.
Johnston NR, Mitchell RK, Haythorne E, Pessoa MP, Semplici F, Ferrer J, Piemonti L, Marchetti P, Bugliani M, Bosco D, Berishvili E, Duncanson P, Watkinson M, Broichhagen J, Trauner D, Rutter GA, Hodson DJ: Beta cell hubs dictate pancreatic islet responses to glucose. Cell Metab 2016; 24: 389–401.
14.
Koppe L, Nyam E, Vivot K, Manning Fox JE, Dai XQ, Nguyen BN, Trudel D, Attané C, Moullé VS, MacDonald PE, Ghislain J, Poitout V: Urea impairs β cell glycolysis and insulin secretion in chronic kidney disease. J Clin Invest 2016; 126: 3598–3612.
15.
Nakamura Y, Yoshida T, Kajiyama S, Kitagawa Y, Kanatsuna T, Kondo M: Insulin release from column-perifused isolated islets of uremic rats. Nephron 1985; 40: 467–469.
16.
Fadda GZ, Hajjar SM, Perna AF, Zhou XJ, Lipson LG, Massry SG: On the mechanism of impaired insulin secretion in chronic renal failure. J Clin Invest 1991; 87: 255–261.
17.
Clark SA, Stumpf WE, Sar M: Effect of 1,25 dihydroxyvitamin D3 on insulin secretion. Diabetes 1981; 30: 382–386.
18.
Porrini EL, Diaz JM, Moreso F, Delgado Mallen PI, Silva Torres I, Ibernon M, Bayes-Genis B, Benitez-Ruiz R, Lampreabe I, Lauzurrica R, Osorio JM, Osuna A, Dominguez-Rollan R, Ruiz JC, Jimenez-Sosa A, Gonzalez-Rinne A, Marrero-Miranda D, Macia M, Garcia J, Torres A: Clinical evolution of post-transplant diabetes mellitus. Nephrol Dial Transplant 2016; 31: 495–505.
19.
Fine NHF, Doig CL, Elhassan YS, Vierra NC, Marchetti P, Bugliani M, Nano R, Piemonti L, Rutter GA, Jacobson DA, Lavery GG, Hodson DJ: Glucocorticoids reprogram β-cell signaling to preserve insulin secretion. Diabetes 2018; 67: 278–290.
20.
Lombardi A, Trimarco B, Iaccarino G, Santulli G: Impaired mitochondrial calcium -uptake caused by tacrolimus underlies -beta-cell failure. Cell Commun Signal 2017; 15: 47.
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.